The present disclosure relates to novel compounds for use in therapeutic treatement of a disease associated with peptidylarginine deiminases (PADs), such as peptidylarginine deiminase type 4 (PAD4). The present disclosure also relates to processes and intermediates for the preparation of such compounds, methods of using such compounds and pharmaceutical compositions comprising the compounds described herein.
本公开涉及用于治疗与肽基精
氨酸
脱亚胺酶(PADs)相关的疾病(例如肽基精
氨酸
脱亚胺酶4型(PA
D4))的新化合物。本公开还涉及用于制备这些化合物的过程和
中间体,使用这些化合物的方法以及包含所述化合物的制药组合物。